Identification of Urinary Metabolite Biomarkers of Type 2 Diabetes Nephropathy Using an Untargeted Metabolomic Approach
Authors:
- 28 September 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 17 (11) , 3997-4007
Abstract
Diabetic nephropathy (DN) is one of the most common complications of diabetes mellitus (DM). To discover early-stage biomarkers of DN, untargeted liquid chromatography-mass spectrometry-based metabolomic analysis was performed in urine samples from healthy subjects and patients with micro- or macroalbuminuria due to nondiabetic disease (macro), type 2 DM without microalbuminuria (T2DM), and type 2 DM with microalbuminuria (T2DM+micro). Levels of four metabolites were significantly different among groups, and they were quantified in a larger group of 267 urine samples. Two metabolites were also discovered and validated in targeted metabolic study of amino acids. For diagnosis of nephropathy, N1-methylguanosine had the highest area-under-the-curve (AUC) value of 0.75 when compared to that of valine (0.68), xanthosine (0.67), and 7-methyluric acid (0.69). After combining fasting blood glucose and diastolic blood pressure (DBP) with N1-methylguanosine, the AUC increased to 0.987. To distinguish between T2DM and T2DM+micro conditions, xanthosine and N1-methylguanosine have AUC value of 0.612 and 0.624, respectively. After adjustment of HbA1c and DBP, AUC values of xanthosine and N1-methylguanosine increased to 0.716 and 0.723, respectively and could be used to predict the development of nephropathy in T2DM patients.Keywords
Funding Information
- National Center of Excellence for Clinical Trial and Research (MOHW107-TDU-B-212-123004)
- China Medical University Hospital (DMR-106-126)
- Academia Sinica (BM 10601010027)
- Ministry of Science and Technology, Taiwan (MOST 105-2113-M-039-001)
This publication has 25 references indexed in Scilit:
- The Human Urine MetabolomePLOS ONE, 2013
- Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetesKidney International, 2013
- US Renal Data System 2011 Annual Data ReportAmerican Journal of Kidney Diseases, 2012
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR)Nephrology Dialysis Transplantation, 2010
- Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traitsMetabolomics, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- The pathogenesis of diabetic nephropathyNature Clinical Practice Endocrinology & Metabolism, 2008
- International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD RiskJournal of the American Society of Nephrology, 2006
- RNA metabolism in uremic patients: Accumulation of modified ribonucleosides in uremic serumKidney International, 1998